KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma

British Journal of Cancer

Volumn 101, Issue 7, 2009, Pages 1107-1113

  White, N M A ^a   Mathews, M ^a   Yousef, G M ^b   Prizada, A ^a   Popadiuk, C ^c   Dore J J E ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c Health Sciences Centre St John's   (Canada)

Author keywords

Biomarkers; Human kallikrein related peptidase 13; Human kallikrein related peptidase 6; Ovarian cancer; Ovarian carcinogenesis

Indexed keywords

KALLIKREIN 13; KALLIKREIN 6; MESSENGER RNA; RNA;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE LOCATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR RECURRENCE;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; REGRESSION ANALYSIS; RNA, MESSENGER;

EID: 70349663978     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605280     Document Type: Article

References (35)

1. Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R (1996) A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med 2: 624-636 (Pubitemid 26353111)
2. Bell DA (2005) Origins and molecular pathology of ovarian cancer. Mod Pathol 18: S19-S32 (Pubitemid 40188615)
3. Borgono CA, Diamandis EP (2004) The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 4: 876-890 (Pubitemid 39472954)
4. Christie M, Oehler MK (2006) Molecular pathology of epithelial ovarian cancer. J Br Menopause Soc 12: 57-63 (Pubitemid 43881064)
5. Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP (2006) Human kallikrein 6 expression in salivary gland tumors. J Histochem Cytochem 54: 337-342 (Pubitemid 43291278)
6. Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P (2000a) Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin Biochem 33: 579-583
7. Diamandis EP, Yousef GM, Soosaipillai AR, Grass L, Porter A, Little S, Sotiropoulou G (2000b) Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin Biochem 33: 369-375 (Pubitemid 30765788)
8. Ghosh MC, Grass L, Soosaipillai A, Sotiropoulou G, Diamandis EP (2004) Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol 25: 193-199 (Pubitemid 39551746)
9. Giordano G, Azzoni C, D'Adda T, Rocco A, Gnetti L, Froio E, Merisio C, Melpignano M (2008) Human papilloma virus (HPV) status, p16(INK4a), and p53 overexpression in epithelial malignant and borderline ovarian neoplasms. Pathol Res Pract 204: 163-174
10. Henkhaus RS, Gerner EW, Ignatenko NA (2008) Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells. Biol Chem 389: 757-764
11. Hoffman BR, Katsaros D, Scorilas A, Diamandis P, Fracchioli S, Rigault de la Longrais IA, Colgan T, Puopolo M, Giardina G, Massobrio M, Diamandis EP (2002) Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br J Cancer 87: 763-771 (Pubitemid 35178754)
12. Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19: 3-10 (Pubitemid 30439309)
13. Kaku T, Ogawa S, Kawano Y, Ohishi Y, Kobayashi H, Hirakawa T, Nakano H (2003) Histological classification of ovarian cancer. Med Electron Microsc 36: 9-17
14. Kapadia C, Chang A, Sotiropoulou G, Yousef GM, Grass L, Soosaipillai A, Xing X, Howarth DH, Diamandis EP (2003) Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay. Clin Chem 49: 77-86 (Pubitemid 36078556)
15. Kapadia C, Ghosh MC, Grass L, Diamandis EP (2004) Human kallikrein 13 involvement in extracellular matrix degradation. Biochem Biophys Res Commun 323: 1084-1090 (Pubitemid 39243429)
16. Klucky B, Mueller R, Vogt I, Teurich S, Hartenstein B, Breuhahn K, Flechtenmacher C, Angel P, Hess J (2007) Kallikrein 6 induces Ecadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res 67: 8198-8206 (Pubitemid 47395156)
17. Kountourakis P, Psyrri A, Scorilas A, Camp R, Markakis S, Kowalski D, Diamandis EP, Dimopoulos MA (2008) Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA). Cancer Sci 99: 2224-2229
18. Little SP, Dixon EP, Norris F, Buckley W, Becker GW, Johnson M, Dobbins JR, Wyrick T, Miller JR, MacKellar W, Hepburn D, Corvalan J, McClure D, Liu X, Stephenson D, Clemens J, Johnstone EM (1997) Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J Biol Chem 272: 25135-25142 (Pubitemid 27415697)
19. Ni X, Zhang W, Huang KC, Wang Y, Ng SK, Mok SC, Berkowitz RS, Ng SW (2004) Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Br J Cancer 91: 725-731 (Pubitemid 39141632)
20. Obata K, Morland SJ, Watson RH, Hitchcock A, Chenevix-Trench G, Thomas EJ, Campbell IG (1998) Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 58: 2095-2097 (Pubitemid 28232892)
21. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M (2005) Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res 11: 2889-2893 (Pubitemid 40525189)
22. Petraki CD, Karavana VN, Diamandis EP (2003) Human kallikrein 13 expression in normal tissues: an immunohistochemical study. J Histochem Cytochem 51: 493-501 (Pubitemid 36418045)
23. Petraki CD, Karavana VN, Skoufogiannis PT, Little SP, Howarth DJ, Yousef GM, Diamandis EP (2001) The spectrum of human kallikrein 6 (zyme/ protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. J Histochem Cytochem 49: 1431-1441
24. Planque C, Li L, Zheng Y, Soosaipillai A, Reckamp K, Chia D, Diamandis EP, Goodglick L (2008) A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma. Clin Cancer Res 14: 1355-1362
25. Press JZ, De Luca A, Boyd N, Young S, Troussard A, Ridge Y, Kaurah P, Kalloger SE, Blood KA, Smith M, Spellman PT, Wang Y, Miller DM, Horsman D, Faham M, Gilks CB, Gray J, Huntsman DG (2008) Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities. BMC Cancer 8: 17-29 (Pubitemid 351279967)
26. Ruckert F, Hennig M, Petraki CD, Wehrum D, Distler M, Denz A, Schroder M, Dawelbait G, Kalthoff H, Saeger HD, Diamandis EP, Pilarsky C, Grutzmann R (2008) Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma. Br J Cancer 99: 1484-1492
27. Santin AD, Diamandis EP, Bellone S, Soosaipillai A, Cane S, Palmieri M, Burnett A, Roman JJ, Pecorelli S (2005) Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Clin Cancer Res 11: 3320-3325 (Pubitemid 40627882)
28. Schink JC (1999) Current initial therapy of stage III and IV ovarian cancer: challenges for managed care. Semin Oncol 26: 2-7
29. Scorilas A, Borgono CA, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP (2004) Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker. J Clin Oncol 22: 678-685 (Pubitemid 41095071)
30. Shan SJ, Scorilas A, Katsaros D, Diamandis EP (2007) Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects. Br J Cancer 96: 362-372 (Pubitemid 46160644)
31. Tanimoto H, Underwood LJ, Shigemasa K, Parmley TH, O'Brien TJ (2001) Increased expression of protease M in ovarian tumors. Tumour Biol 22: 11-18 (Pubitemid 30816524)
32. Yamashiro K, Tsuruoka N, Kodama S, Tsujimoto M, Yamamura Y, Tanaka T, Nakazato H, Yamaguchi N (1997) Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim Biophys Acta 1350: 11-14 (Pubitemid 27025924)
33. Yousef G, Diamandis EP (2003) Human kallikreins: common structural features, sequence analysis and evolution. Curr Genomics 4: 147-165 (Pubitemid 36131696)
34. Yousef GM, Chang A, Diamandis EP (2000) Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues. J Biol Chem 275: 11891-11898 (Pubitemid 30237758)
35. Zheng Y, Katsaros D, Shan SJ, de la Longrais IR, Porpiglia M, Scorilas A, Kim NW, Wolfert RL, Simon I, Li L, Feng Z, Diamandis EP (2007) A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy. Clin Cancer Res 13: 6984-6992 (Pubitemid 350276879)